{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:49:39Z","timestamp":1792028979411,"version":"4.4.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR46424\/MED\/30\/2449\/2023"],"award-info":[{"award-number":["BT\/PR46424\/MED\/30\/2449\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SRG\/2022\/000657"],"award-info":[{"award-number":["SRG\/2022\/000657"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-2341"],"award-info":[{"award-number":["IIRP-2023-2341"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007488","name":"Indian Institute of Technology Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbcan.2025.189383","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:10:41Z","timestamp":1751537441000},"page":"189383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Spatial heterogeneity in glioblastoma: Decoding the role of perfusion"],"prefix":"10.1016","volume":"1880","author":[{"given":"Shubhraneel","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiksha","family":"Kukal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Phalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0005","first-page":"3","article-title":"Glioblastoma Multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment","volume":"18","author":"Hanif","year":"2017","journal-title":"Asian Pacific J. Cancer Prevent.: APJCP"},{"key":"10.1016\/j.bbcan.2025.189383_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189383_bb0015","series-title":"Glioblastoma","first-page":"143","article-title":"Epidemiology and outcome of glioblastoma","author":"Tamimi","year":"2017"},{"issue":"Suppl. 2","key":"10.1016\/j.bbcan.2025.189383_bb0020","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro-Oncology"},{"issue":"suppl_7","key":"10.1016\/j.bbcan.2025.189383_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy090","article-title":"Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014","volume":"20","author":"Gittleman","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0030","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jocn.2010.02.015","article-title":"Glioblastoma of the cerebellum and brainstem","volume":"17","author":"Stark","year":"2010","journal-title":"J. Clin. Neurosci.: Off. J. Neurosurg. Soc. Austral."},{"key":"10.1016\/j.bbcan.2025.189383_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.critrevonc.2017.03.021","article-title":"Central nervous system gliomas","volume":"113","author":"Reni","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030484","article-title":"The many facets of therapy resistance and tumor recurrence in glioblastoma","volume":"10","author":"Goenka","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","article-title":"Glioblastoma: defining tumor niches","volume":"1","author":"Hambardzumyan","year":"2015","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2025.189383_bb0060","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3389\/fimmu.2018.01004","article-title":"Immune microenvironment in glioblastoma subtypes","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2019.04.003","article-title":"Intra-Tumoral metabolic zonation and resultant phenotypic diversification are dictated by blood vessel proximity","volume":"30","author":"Kumar","year":"2019","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0070","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"issue":"6801","key":"10.1016\/j.bbcan.2025.189383_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"38","key":"10.1016\/j.bbcan.2025.189383_bb0085","doi-asserted-by":"crossref","first-page":"23401","DOI":"10.1074\/jbc.M115.664037","article-title":"Glioblastoma-derived macrophage Colony-stimulating factor (MCSF) induces microglial release of insulin-like growth factor-binding protein 1 (IGFBP1) to promote angiogenesis","volume":"290","author":"Nijaguna","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2119\/molmed.2011.00217","article-title":"Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and Colony stimulating factor 1 receptor (CSF-1R) signaling","volume":"18","author":"Coniglio","year":"2012","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10048-024-00763-x","article-title":"Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis","volume":"25","author":"Barbosa","year":"2024","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/cancers6010226","article-title":"Glioblastoma multiforme: a look inside its heterogeneous nature","volume":"6","author":"Inda","year":"2014","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/157488710790820544","article-title":"Current therapeutic paradigms in glioblastoma","volume":"5","author":"Quick","year":"2010","journal-title":"Rev. Recent Clin. Trials"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189383_bb0110","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","article-title":"Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression","volume":"88","author":"Zagzag","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0115","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/0008-5472.CAN-03-2073","article-title":"Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population","volume":"64","author":"Brat","year":"2004","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0002-9440(10)64025-4","article-title":"Glomeruloid microvascular proliferation orchestrated by VPF\/VEGF","volume":"158","author":"Brat","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00125480-200201000-00004","article-title":"Genetic and biologic progression in Astrocytomas and their relation to Angiogenic dysregulation","volume":"9","author":"Brat","year":"2002","journal-title":"Adv. Anat. Pathol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/labinvest.3700070","article-title":"Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma","volume":"84","author":"Brat","year":"2004","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"7484","key":"10.1016\/j.bbcan.2025.189383_bb0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng.3273","article-title":"Mutational landscape and clonal architecture in grade II and III gliomas","volume":"47","author":"Suzuki","year":"2015","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189383_bb0150","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/2159-8290.CD-13-0879","article-title":"EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing","volume":"4","author":"Francis","year":"2014","journal-title":"Cancer Discov."},{"issue":"6190","key":"10.1016\/j.bbcan.2025.189383_bb0155","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"7274","key":"10.1016\/j.bbcan.2025.189383_bb0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"7390","key":"10.1016\/j.bbcan.2025.189383_bb0165","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature10860","article-title":"IDH mutation impairs histone demethylation and results in a block to cell differentiation","volume":"483","author":"Lu","year":"2012","journal-title":"Nature"},{"issue":"7390","key":"10.1016\/j.bbcan.2025.189383_bb0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s40478-021-01221-7","article-title":"Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping","volume":"9","author":"Lyon","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"25","key":"10.1016\/j.bbcan.2025.189383_bb0180","doi-asserted-by":"crossref","first-page":"17228","DOI":"10.1016\/S0021-9258(17)32544-9","article-title":"Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells","volume":"269","author":"Costello","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1215\/15228517-2008-090","article-title":"Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts","volume":"11","author":"Kitange","year":"2009","journal-title":"Neuro-Oncology"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189383_bb0190","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/neuonc\/nou005","article-title":"The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone","volume":"16","author":"Molenaar","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41419-020-03380-2","article-title":"Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc","volume":"12","author":"Lee","year":"2021","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189383_bb0200","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1080\/15384101.2015.1090063","article-title":"The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma","volume":"14","author":"Banelli","year":"2015","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0205","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cam4.1384","article-title":"Long noncoding <scp>RNA MALAT<\/scp> 1 knockdown reverses chemoresistance to temozolomide via promoting micro <scp>RNA<\/scp> -101 in glioblastoma","volume":"7","author":"Cai","year":"2018","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41419-019-1477-5","article-title":"The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells","volume":"10","author":"Mazor","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189383_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135086","article-title":"Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p\/CCT6A pathway","volume":"732","author":"Li","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0220","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","article-title":"Integrative spatial analysis reveals a multi-layered organization of glioblastoma","volume":"187","author":"Greenwald","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0225","article-title":"Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains","volume":"5","author":"Moffet","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0230","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6692","key":"10.1016\/j.bbcan.2025.189383_bb0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1\u03b1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"issue":"6398","key":"10.1016\/j.bbcan.2025.189383_bb0240","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0245","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cub.2021.11.040","article-title":"Calpain-2 regulates hypoxia\/HIF-induced plasticity toward amoeboid cancer cell migration and metastasis","volume":"32","author":"Te Boekhorst","year":"2022","journal-title":"Curr. Biol.: CB"},{"issue":"18","key":"10.1016\/j.bbcan.2025.189383_bb0250","article-title":"Spatiotemporal insights into glioma oncostream dynamics: unraveling formation, stability, and disassembly pathways","volume":"11","author":"Faisal","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0255","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1038\/s41467-022-31340-1","article-title":"Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression","volume":"13","author":"Comba","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0260","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/1097-0142(19890715)64:2<442::AID-CNCR2820640217>3.0.CO;2-S","article-title":"Intratumoral histologic heterogeneity of gliomas. A quantitative study","volume":"64","author":"Paulus","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/neuonc\/3.3.193","article-title":"Limitations of stereotactic biopsy in the initial management of gliomas","volume":"3","author":"Jackson","year":"2001","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1102\/1470-7330.2013.0015","article-title":"Quantifying tumour heterogeneity with CT","volume":"13","author":"Ganeshan","year":"2013","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.bbcan.2025.189383_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.radonc.2019.01.008","article-title":"Low perfusion compartments in glioblastoma quantified by advanced magnetic resonance imaging and correlated with patient survival","volume":"134","author":"Li","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0280","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00598951","article-title":"Magnetic resonance imaging and histopathology of cerebral gliomas","volume":"34","author":"Watanabe","year":"1992","journal-title":"Neuroradiology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0285","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1007\/s00330-020-06702-2","article-title":"Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas","volume":"30","author":"Wu","year":"2020","journal-title":"Eur. Radiol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0290","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/bfgp\/elad002","article-title":"Machine learning applications on intratumoral heterogeneity in glioblastoma using single-cell RNA sequencing data","volume":"22","author":"Arteaga-Arteaga","year":"2023","journal-title":"Brief. Funct. Genomics"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0295","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/neuonc\/noad259","article-title":"Cluster-based prognostication in glioblastoma: unveiling heterogeneity based on diffusion and perfusion similarities","volume":"26","author":"Foltyn-Dumitru","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"Supplement 1","key":"10.1016\/j.bbcan.2025.189383_bb0300","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/neurosurgery\/23.CN_suppl_1.440","article-title":"The role of vascular proliferation in the growth of brain tumors","volume":"23","author":"Brem","year":"1976","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0305","doi-asserted-by":"crossref","DOI":"10.1007\/BF00230490","article-title":"Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms","volume":"85","author":"Wesseling","year":"1993","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189383_bb0310","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/bjc.2013.218","article-title":"Integrin \u03b13 is overexpressed in glioma stem-like cells and promotes invasion","volume":"108","author":"Nakada","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0315","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/cdd.2015.131","article-title":"Integrin \u03b15\u03b21 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma","volume":"23","author":"Renner","year":"2016","journal-title":"Cell Death Differ."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189383_bb0320","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.4161\/cc.9.15.12710","article-title":"The perivascular niche microenvironment in brain tumor progression","volume":"9","author":"Charles","year":"2010","journal-title":"Cell Cycle"},{"issue":"14","key":"10.1016\/j.bbcan.2025.189383_bb0325","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-13-3119","article-title":"VEGF regulates region-specific localization of perivascular bone marrow\u2013derived cells in Glioblastoma","volume":"74","author":"Burrell","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111511","article-title":"A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration","volume":"41","author":"Ghochani","year":"2022","journal-title":"Cell Rep."},{"issue":"31","key":"10.1016\/j.bbcan.2025.189383_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201888","article-title":"Perivascular stromal cells instruct glioblastoma invasion, proliferation, and therapeutic response within an engineered brain perivascular niche model","volume":"9","author":"Ngo","year":"2022","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0340","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.23674","article-title":"Laminin alpha 2 enables glioblastoma stem cell growth","volume":"72","author":"Lathia","year":"2012","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2009.07.014","article-title":"Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9","volume":"289","author":"Kenig","year":"2010","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A perivascular niche for brain tumor stem cells","volume":"11","author":"Calabrese","year":"2007","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.bbcan.2025.189383_bb0355","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1158\/0008-5472.CAN-10-4269","article-title":"Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of Cancer stem-like cells","volume":"71","author":"Zhu","year":"2011","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189383_bb0360","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1039\/D1LC00271F","article-title":"On-chip perivascular niche supporting stemness of patient-derived glioma cells in a serum-free, flowable culture","volume":"21","author":"Gerigk","year":"2021","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0365","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cell.2013.02.021","article-title":"Glioblastoma stem cells generate vascular Pericytes to support vessel function and tumor growth","volume":"153","author":"Cheng","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0370","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cell.2011.06.006","article-title":"Glioma stem cell proliferation and tumor growth are promoted by nitric oxide Synthase-2","volume":"146","author":"Eyler","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2010.01.001","article-title":"Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells","volume":"6","author":"Charles","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2025.189383_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100872","article-title":"Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma","volume":"36","author":"Al-Holou","year":"2023","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189383_bb0385","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tips.2017.05.002","article-title":"Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies","volume":"38","author":"Qiu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0390","first-page":"2037","article-title":"Neuropathology for the neuroradiologist: palisades and pseudopalisades","volume":"27","author":"Wippold","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"20","key":"10.1016\/j.bbcan.2025.189383_bb0395","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","article-title":"The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype","volume":"8","author":"Heddleston","year":"2009","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0400","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/brain\/awq042","article-title":"A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2\u03b1","volume":"133","author":"Seidel","year":"2010","journal-title":"Brain"},{"issue":"7390","key":"10.1016\/j.bbcan.2025.189383_bb0405","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation","volume":"483","author":"Koivunen","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0410","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0002-9440(10)61225-4","article-title":"In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation","volume":"167","author":"Riemenschneider","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0415","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.18632\/oncotarget.6730","article-title":"EGFRvIII\/integrin \u03b23 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/bjc.2017.157","article-title":"CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells","volume":"117","author":"Maciaczyk","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0425","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11033-015-3858-x","article-title":"Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K","volume":"42","author":"Courtnay","year":"2015","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123544","article-title":"Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma","volume":"10","author":"Sanzey","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0435","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1568009616666151222150543","article-title":"Lactate transporters and pH regulation: potential therapeutic targets in glioblastomas","volume":"16","author":"Miranda-Goncalves","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0440","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0169-328X(94)90183-X","article-title":"Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors","volume":"27","author":"Boado","year":"1994","journal-title":"Mol. Brain Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0445","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1007\/s13277-016-5219-3","article-title":"miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1","volume":"37","author":"Guo","year":"2016","journal-title":"Tumour Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189383_bb0450","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm.4415","article-title":"Targeting glioma stem cells through combined BMI1 and EZH2 inhibition","volume":"23","author":"Jin","year":"2017","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189383_bb0455","doi-asserted-by":"crossref","first-page":"8644","DOI":"10.1073\/pnas.1221478110","article-title":"Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3","volume":"110","author":"Mao","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0460","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189383_bb0465","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.18632\/oncotarget.3365","article-title":"Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme","volume":"6","author":"Brown","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0470","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1038\/s41467-022-33235-7","article-title":"Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells","volume":"13","author":"Adnani","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0475","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41525-019-0108-5","article-title":"Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles","volume":"5","author":"Guardia","year":"2020","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.bbcan.2025.189383_bb0480","doi-asserted-by":"crossref","DOI":"10.1172\/JCI36843","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0485","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.bbamcr.2016.03.013","article-title":"Monocarboxylate transporters in the brain and in cancer","volume":"1863","author":"P\u00e9rez-Escuredo","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Cell Res."},{"issue":"6005","key":"10.1016\/j.bbcan.2025.189383_bb0490","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189383_bb0495","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/nn2014","article-title":"Local self-renewal can sustain CNS microglia maintenance and function throughout adult life","volume":"10","author":"Ajami","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"30","key":"10.1016\/j.bbcan.2025.189383_bb0500","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.0804273106","article-title":"Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion","volume":"106","author":"Markovic","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0505","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/labinvest.2011.128","article-title":"Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model","volume":"92","author":"Wang","year":"2012","journal-title":"Lab. Investig."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189383_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023902","article-title":"Characteristics of the alternative phenotype of microglia\/macrophages and its modulation in experimental gliomas","volume":"6","author":"Gabrusiewicz","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189383_bb0515","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/14737175.2018.1510321","article-title":"Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies","volume":"18","author":"Morisse","year":"2018","journal-title":"Expert. Rev. Neurother."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189383_bb0520","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","article-title":"Cellular and molecular identity of tumor-associated macrophages in glioblastoma","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"issue":"28","key":"10.1016\/j.bbcan.2025.189383_bb0525","doi-asserted-by":"crossref","first-page":"14254","DOI":"10.1073\/pnas.1902366116","article-title":"Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189383_bb0530","doi-asserted-by":"crossref","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Reports"},{"issue":"15","key":"10.1016\/j.bbcan.2025.189383_bb0535","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps - myth or reality?","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci. (Lond. Engl. 1979)"},{"key":"10.1016\/j.bbcan.2025.189383_bb0540","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coi.2018.03.009","article-title":"Plasticity of myeloid-derived suppressor cells in cancer","volume":"51","author":"Tcyganov","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116644","article-title":"Glioma-associated microglia\/macrophages display an expression profile Different from M1 and M2 polarization and highly express Gpnmb and Spp1","volume":"10","author":"Szulzewsky","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0550","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41590-022-01215-0","article-title":"Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression","volume":"23","author":"Yeo","year":"2022","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189383_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043339","article-title":"Increased microglia\/macrophage gene expression in a subset of adult and pediatric Astrocytomas","volume":"7","author":"Engler","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0560","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","article-title":"Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma","volume":"39","author":"Hara","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189383_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.710695","article-title":"Single-cell transcriptomics of glioblastoma reveals a unique tumor microenvironment and potential immunotherapeutic target against tumor-associated macrophage","volume":"11","author":"Cui","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189383_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166534","article-title":"Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression","volume":"1868","author":"Chen","year":"2022","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"24","key":"10.1016\/j.bbcan.2025.189383_bb0575","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1158\/0008-5472.CAN-14-1240","article-title":"RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res."},{"issue":"51","key":"10.1016\/j.bbcan.2025.189383_bb0580","doi-asserted-by":"crossref","first-page":"83976","DOI":"10.18632\/oncotarget.6930","article-title":"Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation","volume":"7","author":"Rong","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0585","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41419-021-03664-1","article-title":"Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189383_bb0590","first-page":"1","article-title":"Hypoxia-driven M2-polarized macrophages facilitate cancer aggressiveness and Temozolomide resistance in glioblastoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0595","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ccell.2022.08.014","article-title":"Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity","volume":"40","author":"Chryplewicz","year":"2022","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0600","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","article-title":"Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189383_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189383_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00418","article-title":"Gliomas and the vascular fragility of the blood brain barrier","volume":"8","author":"Dubois","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0615","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","article-title":"A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0620","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2025.189383_bb0625","article-title":"T-cell exhaustion status under high and low levels of hypoxia-inducible factor 1\u03b1 expression in glioma","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189383_bb0630","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma","volume":"24","author":"Woroniecka","year":"2018","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"7355","key":"10.1016\/j.bbcan.2025.189383_bb0635","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.bbcan.2025.189383_bb0640","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016195","article-title":"Hypoxia potentiates glioma-mediated immunosuppression","volume":"6","author":"Wei","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189383_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2023.07.015","article-title":"CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma","volume":"56","author":"Chen","year":"2023","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0655","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1159\/000464429","article-title":"Hypoxia enhances immunosuppression by inhibiting CD4+ effector T cell function and promoting Treg activity","volume":"41","author":"Westendorf","year":"2017","journal-title":"Cell. Physiol. Biochem.: Intern. J. Exper. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189383_bb0660","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2020.01906","article-title":"Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0665","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/nn.3510","article-title":"Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake","volume":"16","author":"Flavahan","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0670","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189383_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115518","article-title":"The acidic brain-glycolytic switch in the microenvironment of malignant glioma","volume":"22","author":"Reuss","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189383_bb0680","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189383_bb0685","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1016\/j.wneu.2018.08.133","article-title":"Difference in immunosuppressive cells between Peritumoral area and tumor core in glioblastoma","volume":"120","author":"Tamura","year":"2018","journal-title":"World Neurosurg."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0690","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2026019","article-title":"Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma","volume":"11","author":"Kim","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2025.189383_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01451","article-title":"CD4+ and perivascular Foxp3+ T cells in glioma correlate with angiogenesis and tumor progression","volume":"8","author":"Mu","year":"2017","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0700","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","article-title":"Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39","volume":"22","author":"Takenaka","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0705","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","article-title":"The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells","volume":"138","author":"Lindau","year":"2013","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189383_bb0710","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/ijc.28622","article-title":"Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways","volume":"134","author":"Raber","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0715","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1\u03b1 induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0720","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2013.08.025","article-title":"Myeloid-derived suppressor cells enhance Stemness of Cancer cells by inducing MicroRNA101 and suppressing the corepressor CtBP2","volume":"39","author":"Cui","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0725","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189383_bb0730","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances Cancer therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0735","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ajpath.2013.10.015","article-title":"Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal\u2212\/\u2212 mice","volume":"184","author":"Ding","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0740","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1108515","article-title":"Myeloid cells in the tumor microenvironment: role of adenosine","volume":"5","author":"Morello","year":"2016","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0745","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/s41598-019-39345-5","article-title":"Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment","volume":"9","author":"Iwahori","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189383_bb0750","article-title":"Quantitative analysis of immune cells within the tumor microenvironment of glioblastoma and their relevance for prognosis","volume":"142","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0755","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/neuonc\/nov280","article-title":"CD4 + T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients","volume":"18","author":"Dubinski","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179012","article-title":"Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane","volume":"12","author":"Kumar","year":"2017","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/j.bbcan.2025.189383_bb0765","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41388-018-0261-9","article-title":"Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a\/Rora and miR-21\/Pten pathways","volume":"37","author":"Guo","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032453","article-title":"Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment","volume":"7","author":"Katz","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0775","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nn.4493","article-title":"Identification of diverse astrocyte populations and their malignant analogs","volume":"20","author":"John Lin","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054752","article-title":"Astrocytes enhance the invasion potential of glioblastoma stem-like cells","volume":"8","author":"Rath","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0785","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147087","article-title":"Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects","volume":"133","author":"Jain","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189383_bb0790","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fendo.2018.00318","article-title":"Temozolomide and pituitary tumors: current understanding, unresolved issues, and future directions","volume":"9","author":"Syro","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0795","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41571-022-00623-3","article-title":"Author correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"19","author":"Weller","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0800","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189383_bb0805","article-title":"Anti-angiogenic therapy for high-grade glioma","volume":"11","author":"Ameratunga","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0810","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(18)30675-2","article-title":"Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"20","author":"Lombardi","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2025.189383_bb0815","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/698542","article-title":"An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab","volume":"2014","author":"Lombardi","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189383_bb0820","article-title":"Stereotactic radiosurgery for glioblastoma","volume":"7","author":"Redmond","year":"2015","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0825","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/nop\/npac019","article-title":"Safe surgery for glioblastoma: recent advances and modern challenges","volume":"9","author":"Gerritsen","year":"2022","journal-title":"Neuro-Oncol. Pract."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0830","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10143-016-0727-6","article-title":"The role of brachytherapy in the treatment of glioblastoma multiforme","volume":"40","author":"Barbarite","year":"2017","journal-title":"Neurosurg. Rev."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0835","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ijc.28576","article-title":"Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy","volume":"134","author":"Weller","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189383_bb0840","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/neuonc\/nov013","article-title":"Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas","volume":"17","author":"van den Bent","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189383_bb0845","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv439","article-title":"Chimeric antigen receptors modified T-cells for cancer therapy","volume":"108","author":"Dai","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189383_bb0850","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.4161\/hv.29276","article-title":"DCVax\u00ae-L--developed by Northwest Biotherapeutics","volume":"10","author":"Polyzoidis","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0855","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/noac099","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial","volume":"25","author":"Omuro","year":"2023","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0860","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12885-020-6624-y","article-title":"A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol","volume":"20","author":"Brown","year":"2020","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189383_bb0865","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1158\/1078-0432.CCR-21-4064","article-title":"Circulating immune cell and outcome analysis from the phase II study of PD-L1 blockade with Durvalumab for newly diagnosed and recurrent glioblastoma","volume":"28","author":"Nayak","year":"2022","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189383_bb0870","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1172\/JCI138649","article-title":"Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"399","key":"10.1016\/j.bbcan.2025.189383_bb0875","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0880","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0885","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189383_bb0890","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1158\/1078-0432.CCR-19-0261","article-title":"A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma","volume":"25","author":"Wen","year":"2019","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189383_bb0895","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.22.00996","article-title":"Phase IIa study of SurVaxM plus adjuvant Temozolomide for newly diagnosed glioblastoma","volume":"41","author":"Ahluwalia","year":"2023","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189383_bb0900","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1470-2045(13)70274-2","article-title":"Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial","volume":"14","author":"Westphal","year":"2013","journal-title":"Lancet Oncol."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189383_bb0905","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0910","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41467-022-31262-y","article-title":"A phase I\/II study of triple-mutated oncolytic herpes virus G47\u2206 in patients with progressive glioblastoma","volume":"13","author":"Todo","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189383_bb0915","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S1470-2045(23)00347-9","article-title":"Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial","volume":"24","author":"Umemura","year":"2023","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0920","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13046-022-02431-0","article-title":"PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C\/EBP\u03b2 degradation to facilitate proneural-to-mesenchymal transition","volume":"41","author":"Gao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0925","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.415","article-title":"Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma","volume":"28","author":"Pistollato","year":"2010","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0930","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/neuonc\/nos195","article-title":"Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1","volume":"14","author":"Chou","year":"2012","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0935","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-018-2894-5","article-title":"Down-regulation of MDR1 by ad-DKK3 via Akt\/NF\u03baB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model","volume":"139","author":"Fujihara","year":"2018","journal-title":"J. Neuro-Oncol."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189383_bb0940","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/onc.2009.27","article-title":"Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution","volume":"28","author":"Piccirillo","year":"2009","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041228","article-title":"The adenosine A\u2083 receptor regulates differentiation of glioblastoma stem-like cells to endothelial cells under hypoxia","volume":"19","author":"Rocha","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189383_bb0950","article-title":"Comparison of dosimetric gains provided by intensity-modulated radiotherapy, volume-modulated arc therapy, and helical Tomotherapy for high-grade glioma","volume":"2020","author":"Liu","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189383_bb0955","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/ars.2015.6589","article-title":"Targeted inhibition of glutamine-dependent glutathione metabolism overcomes death resistance induced by chronic cycling hypoxia","volume":"25","author":"Matschke","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189383_bb0960","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3892\/ijo.2014.2358","article-title":"Hypoxia sustains glioblastoma radioresistance through ERKs\/DNA-PKcs\/HIF-1\u03b1 functional interplay","volume":"44","author":"Marampon","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0965","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-15-2058","article-title":"FGFR1 induces glioblastoma Radioresistance through the PLC\u03b3\/Hif1\u03b1 pathway","volume":"76","author":"Gouaz\u00e9-Andersson","year":"2016","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb0970","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030112","article-title":"Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma","volume":"10","author":"Rahimi Koshkaki","year":"2020","journal-title":"J. Pers. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb0975","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ccell.2018.03.020","article-title":"A glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment","volume":"33","author":"Griveau","year":"2018","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb0980","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/neuonc\/nox070","article-title":"Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas","volume":"19","author":"Weil","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb0985","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/neuonc\/now014","article-title":"A malignant cellular network in gliomas: potential clinical implications","volume":"18","author":"Osswald","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189383_bb0990","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-022-00475-0","article-title":"Disconnecting multicellular networks in brain tumours","volume":"22","author":"Venkataramani","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb0995","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BCJ20200710","article-title":"Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids","volume":"478","author":"Pinto","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2025.189383_bb1000","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mam.2017.01.009","article-title":"Multidrug resistance in glioblastoma stem-like cells: role of the hypoxic microenvironment and adenosine signaling","volume":"55","author":"Uribe","year":"2017","journal-title":"Mol. Asp. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189383_bb1005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10456-022-09830-z","article-title":"Identification of vascular cues contributing to cancer cell stemness and function","volume":"25","author":"Kumar","year":"2022","journal-title":"Angiogenesis"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189383_bb1010","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99048","article-title":"Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity","volume":"3","author":"Wang","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb1015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41467-024-55455-9","article-title":"Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma","volume":"16","author":"Grimes","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb1020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22439-y","article-title":"Hydrogel-based microfluidic device with multiplexed 3D in vitro cell culture","volume":"12","author":"Clancy","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189383_bb1025","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","article-title":"Glioblastoma Model Using Human Cerebral Organoids","volume":"23","author":"Ogawa","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189383_bb1030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189383_bb1035","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1007\/s00330-020-07414-3","article-title":"Diffusion and perfusion MRI radiomics obtained from deep learning segmentation provides reproducible and comparable diagnostic model to human in post-treatment glioblastoma","volume":"31","author":"Park","year":"2021","journal-title":"Eur. Radiol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:08:03Z","timestamp":1762290483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":207,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0304419X25001258"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189383","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial heterogeneity in glioblastoma: Decoding the role of perfusion","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189383"}}